Correlation Between Puma Biotechnology and Vanda Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Puma Biotechnology and Vanda Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Puma Biotechnology and Vanda Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Puma Biotechnology and Vanda Pharmaceuticals, you can compare the effects of market volatilities on Puma Biotechnology and Vanda Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Puma Biotechnology with a short position of Vanda Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Puma Biotechnology and Vanda Pharmaceuticals.

Diversification Opportunities for Puma Biotechnology and Vanda Pharmaceuticals

0.79

Correlation Coefficient

Puma Biotechnology  Vanda Pharmaceuticals

Poor diversification

The 3 months correlation between Puma and Vanda is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Puma Biotechnology and Vanda Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vanda Pharmaceuticals and Puma Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Puma Biotechnology are associated (or correlated) with Vanda Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vanda Pharmaceuticals has no effect on the direction of Puma Biotechnology i.e., Puma Biotechnology and Vanda Pharmaceuticals go up and down completely randomly.

Pair Corralation between Puma Biotechnology and Vanda Pharmaceuticals

Given the investment horizon of 90 days Puma Biotechnology is expected to generate 2.58 times less return on investment than Vanda Pharmaceuticals. But when comparing it to its historical volatility, Puma Biotechnology is 1.28 times less risky than Vanda Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. Vanda Pharmaceuticals is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  540.00  in Vanda Pharmaceuticals on October 6, 2025 and sell it today you would earn a total of  285.00  from holding Vanda Pharmaceuticals or generate 52.78% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Puma Biotechnology  vs.  Vanda Pharmaceuticals

Puma Biotechnology

Risk-Adjusted Performance

Mild

Compared to the overall equity markets, risk-adjusted returns on investments in Puma Biotechnology are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite fairly unfluctuating basic indicators, Puma Biotechnology demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Vanda Pharmaceuticals

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Vanda Pharmaceuticals are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat abnormal fundamental indicators, Vanda Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Puma Biotechnology and Vanda Pharmaceuticals

The main advantage of trading using opposite Puma Biotechnology and Vanda Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Puma Biotechnology position performs unexpectedly, Vanda Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vanda Pharmaceuticals will offset losses from the drop in Vanda Pharmaceuticals' long position.

The idea behind Puma Biotechnology and Vanda Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.